<DOC>
	<DOCNO>NCT00661245</DOCNO>
	<brief_summary>The TOGA® trial prospective , multi-center , randomized sham-controlled trial design determine safety effectiveness TOGA System treatment morbid obesity . The study also determine effect treatment co-morbidities quality life . Subjects blind treatment sham . Sham arm may crossover TOGA treatment 12 month .</brief_summary>
	<brief_title>Transoral Gastroplasty Treatment Morbid Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>1 . Age 1860 2 . BMI ≥ 40 kg/m2 &lt; 55 kg/m2 , BMI ≥ 35 kg/m2 one significant co morbidity 3 . History obesity least 2.5 year . 4 . History stable weight ( define &lt; 10 % change excess weight ) one year prior screen visit . 5 . History failure nonsurgical weight loss method . 6 . Suitable candidate bariatric surgery base result psychological physical evaluation . 7 . Understands risks procedure , agree follow protocol requirement , include signing informed consent , return followup visit , complete require testing , complete diet behavior modification counseling , commit prolonged lifestyle change , agree comply substantial dietary restriction require procedure . 8 . Subject life , intend remain , within 100 mile radius study center 5 year . 1 . Hormonal genetic cause obese state . 2 . History cancer localize basal cell carcinoma . 3 . History inflammatory disease gastrointestinal tract include Crohn 's disease , ulcerative colitis , severe intractable esophagitis , gastric ulceration , esophageal duodenal ulceration . 4 . Active peptic ulcer disease . 5 . Significant known esophageal disease , include Zenker 's diverticulum , grade 34 reflux esophagitis , stricture , Barrett 's esophagus , esophageal cancer , esophageal diverticulum , dysphagia , achalasia , diffuse esophageal spasm , symptoms dysmotility . 6 . Myocardial infarction cerebrovascular accident within past year . 7 . Angina pectoris . 8 . Inability extend neck fully open mouth . 9 . Clinically severe cervical spinal disease , include cervical disc disease , vertebral osteophyte . 10 . Critically loose teeth . 11 . Temporomandibular joint syndrome ( TMJ ) patient risk develop TMJ . 12 . Severe coagulopathy ( prothrombin time &gt; 3 second control platelet count &lt; 100,000 ) 13 . Gastroparesis 14 . Upper GI bleed condition esophageal gastric varix , portal hypertensive gastropathy , congenital acquire intestinal telangiectasis . 15 . Congenital acquire anomaly GI tract atresia stenosis . 16 . Structural abnormality GI tract diverticulum . 17 . Lesions increase risk bleeding . 18 . Hiatal hernia ≥ 2cm . 19 . Severe cardiopulmonary disease serious organic disease , include HIV cancer . 20 . Congestive heart failure . 21 . Uncontrolled hypertension ( systolic &gt; 150 diastolic &gt; 100 ) . 22 . Advanced rheumatoid arthritis . 23 . Severe advance liver disease ( cirrhosis , chronic hepatitis , portal hypertension , etc. ) . 24 . Chronic pancreatitis . 25 . Any contraindication endoscopy . 26 . Severe reflux disease . 27 . Currently pregnant nursing . 28 . Potentially childbearing ( i.e . postmenopausal surgically sterilize ) willing use effective method contraception next 24 month . 29 . Alcohol ( &gt; 80 gm/day ethanol ) illicit drug use within last 3 year . 30 . Prior gastric , esophageal , pancreatic bariatric surgery . 31 . Currently prescription counter diet drug . 32 . Chronic therapy aspirin , NSAID anticoagulant . 33 . Systemic infection time procedure . 34 . Patient known diagnosis preexisting symptom autoimmune connective tissue disease ( i.e. , systemic lupus erythematosus scleroderma ) . 35 . Thyroid disease control medication 36 . Unacceptable medical risk ( general health status would preclude surgery complication occur ) . 37 . Not ambulatory . 38 . Participating another ongoing clinical trial concomitant diagnosis therapeutic intervention would adversely affect integrity clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>